Simply Solventless Concentrates Ltd. Stock
Stocks
HASH
CA82888A1021
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Toronto S.E.
2026-10-20
|
5-day change | 1st Jan Change | ||
| 0.0450 CAD | -10.00% |
|
-18.18% | -67.86% |
| Market Cap | 5.2M 3.7M 3.29M 3.05M 2.77M 350M 5.28M 36.62M 14.39M 183M 13.88M 13.59M 585M | P/E 2024 |
-10x | P/E 2025 | -0.58x |
|---|---|---|---|---|---|
| Enterprise Value | 22.2M 15.8M 14.07M 13.04M 11.81M 1.5B 22.57M 156M 61.45M 783M 59.28M 58.05M 2.5B | EV / Sales 2024 |
6.8x | EV / Sales 2025 | 1.14x |
| Free-Float |
80.79% | Yield 2024 * |
-
| Yield 2025 | - |
Toronto S.E.CAD
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| HASH | End-of-day quote | |
OTC Markets
| SSLCF | Delayed | |
|
Deutsche Boerse AG
| Y3I | Delayed |
| 1 day | -10.00% | ||
| 1 week | -18.18% | ||
| 1 month | -10.00% | ||
| 3 months | -30.77% | ||
| 6 months | +12.50% | ||
| Current year | -67.86% |
| 1 week | 0.04 |  | 0.06 |
| 1 month | 0.04 | | 0.06 |
| Current year | 0.04 | | 0.19 |
| 1 year | 0.04 | | 0.26 |
| 3 years | 0.04 | | 0.84 |
| 5 years | 0.04 | | 0.84 |
| 10 years | 0.04 | | 0.84 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 2/10/26 | Buy | Director | 5,500 | 0.0057% | ||
| 2/10/26 | Buy | Director | 5,000 | 0.0052% | ||
| 2/10/26 | Buy | Director | 9,500 | 0.0098% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -10.00% | -18.18% | -81.25% | -82.69% | 3.7M | |
| +3.49% | +10.04% | +58.68% | +119.56% | 1,144B | |
| +2.19% | +4.32% | +33.88% | +69.52% | 625B | |
| +2.26% | +5.37% | +24.57% | +97.69% | 511B | |
| +0.19% | +5.18% | +38.92% | +64.22% | 377B | |
| +3.25% | +4.45% | +71.80% | +44.44% | 366B | |
| +0.12% | +3.21% | +21.08% | +49.82% | 291B | |
| -0.04% | +2.54% | +1.11% | +24.88% | 262B | |
| +3.29% | +6.32% | +44.71% | +57.43% | 237B | |
| +2.25% | +5.81% | +27.13% | +101.17% | 194B | |
| Average | -1.19% | +3.86% | +24.06% | +54.60% | 400.79B | |
| Weighted average by Cap. | -0.24% | +6.91% | +40.95% | +81.08% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 13.68M 9.74M 8.67M 8.03M 7.28M 922M 13.91M 96.38M 37.86M 483M 36.52M 35.77M 1.54B | 29.06M 20.68M 18.41M 17.06M 15.46M 1.96B 29.55M 205M 80.43M 1.03B 77.59M 75.98M 3.27B |
| Net income | -5.19M -3.7M -3.29M -3.05M -2.76M -350M -5.28M -36.6M -14.38M -183M -13.87M -13.58M -585M | -27.33M -19.45M -17.31M -16.05M -14.54M -1.84B -27.79M -193M -75.64M -964M -72.97M -71.45M -3.08B |
| Net Debt | 9.1M 6.48M 5.77M 5.34M 4.84M 614M 9.25M 64.12M 25.19M 321M 24.3M 23.79M 1.02B | 17M 12.1M 10.77M 9.98M 9.05M 1.15B 17.29M 120M 47.06M 600M 45.4M 44.46M 1.91B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-20 | CA$0.0450 | -10.00% | 10,021 |
| 26-10-19 | CA$0.0500 | -9.09% | 47,500 |
| 26-10-15 | CA$0.0550 | 0.00% | 6,000 |
| 26-10-14 | CA$0.0550 | 0.00% | 19,000 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- HASH Stock
Select your edition
All financial news and data tailored to specific country editions
